GW & Wade’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $237K | Buy |
1,128
+3
| +0.3% | +$640 | 0.01% | 371 |
|
|
2023
Q3 | $225K | Sell |
1,125
-10
| -0.9% | -$1.99K | 0.01% | 364 |
|
|
2023
Q2 | $210K | Sell |
1,135
-212
| -16% | -$39.2K | 0.01% | 361 |
|
|
2023
Q1 | $258K | Sell |
1,347
-111
| -8% | -$20.1K | 0.01% | 331 |
|
|
2022
Q4 | $245K | Buy |
1,458
+81
| +6% | +$14.1K | 0.01% | 338 |
|
|
2022
Q3 | $244K | Sell |
1,377
-76
| -5% | -$15K | 0.01% | 333 |
|
|
2022
Q2 | $297K | Buy |
1,453
+58
| +4% | +$12.3K | 0.01% | 306 |
|
|
2022
Q1 | $332K | Buy |
1,395
+9
| +0.6% | +$2.11K | 0.01% | 292 |
|
|
2021
Q4 | $317K | Buy |
+1,386
| New | +$305K | 0.01% | 313 |
|
|
2021
Q3 | – | Sell |
-1,002
| Closed | -$213K | – | 381 |
|
|
2021
Q2 | $213K | Sell |
1,002
-3
| -0.3% | -$633 | 0.01% | 361 |
|
|
2021
Q1 | $205K | Sell |
1,005
-181
| -15% | -$35.6K | 0.01% | 342 |
|
|
2020
Q4 | $216K | Buy |
+1,186
| New | +$202K | 0.01% | 293 |
|
|
2020
Q3 | – | Sell |
-1,530
| Closed | -$249K | – | 243 |
|
|
2020
Q2 | $249K | Sell |
1,530
-296
| -16% | -$53.1K | 0.02% | 216 |
|
|
2020
Q1 | $316K | Buy |
1,826
+43
| +2% | +$8.56K | 0.03% | 168 |
|
|
2019
Q4 | $358K | Sell |
1,783
-406
| -19% | -$83.3K | 0.03% | 178 |
|
|
2019
Q3 | $463K | Buy |
2,189
+3
| +0.1% | +$627 | 0.04% | 152 |
|
|
2019
Q2 | $424K | Buy |
2,186
+92
| +4% | +$17K | 0.04% | 157 |
|
|
2019
Q1 | $345K | Buy |
2,094
+213
| +11% | +$37.7K | 0.03% | 174 |
|
|
2018
Q4 | $354K | Buy |
1,881
+2
| +0.1% | +$369 | 0.04% | 163 |
|
|
2018
Q3 | $320K | Buy |
1,879
+1
| +0.1% | +$168 | 0.03% | 182 |
|
|
2018
Q2 | $308K | Buy |
1,878
+219
| +13% | +$35.8K | 0.03% | 183 |
|
|
2018
Q1 | $268K | Buy |
1,659
+100
| +6% | +$15.9K | 0.03% | 192 |
|
|
2017
Q4 | $228K | Sell |
1,559
-2,717
| -64% | -$387K | 0.03% | 201 |
|
|
2017
Q3 | $580K | Buy |
4,276
+70
| +2% | +$8.84K | 0.07% | 129 |
|
|
2017
Q2 | $527K | Hold |
4,206
| – | – | 0.07% | 132 |
|
|
2017
Q1 | $500K | Sell |
4,206
-1,203
| -22% | -$145K | 0.07% | 136 |
|
|
2016
Q4 | $624K | Sell |
5,409
-43
| -0.8% | -$4.79K | 0.1% | 115 |
|
|
2016
Q3 | $570K | Buy |
5,452
+151
| +3% | +$15.8K | 0.1% | 116 |
|
|
2016
Q2 | $516K | Hold |
5,301
| – | – | 0.09% | 138 |
|
|
2016
Q1 | $509K | Hold |
5,301
| – | – | 0.1% | 117 |
|
|
2015
Q4 | $480K | Sell |
5,301
-230
| -4% | -$21.6K | 0.1% | 121 |
|
|
2015
Q3 | $513K | Buy |
5,531
+100
| +2% | +$9.51K | 0.11% | 111 |
|
|
2015
Q2 | $505K | Sell |
5,431
-46
| -0.8% | -$4.29K | 0.1% | 129 |
|
|
2015
Q1 | $519K | Buy |
+5,477
| New | +$507K | 0.1% | 129 |
|
Other funds holding CME
GW & Wade's CME Position: Q4 2023 in Review
GW & Wade increased its CME Group (CME) stake by 0.27% in Q4 2023, buying an estimated $640 and bringing the position to 1,128 shares worth $237K. The position accounts for 0.01% of the portfolio, ranked #371.
GW & Wade first reported a position in CME in Q1 2015 and has held it in 34 quarters since. The position peaked at $624K in Q4 2016. 1,364 funds tracked by Wall St. Rank hold CME as of Q4 2023.
- GW & Wade held 1,128 shares of CME Group worth $237K as of Q4 2023.
- GW & Wade bought 3 CME Group shares in Q4 2023, an estimated $640.
- CME Group made up 0.01% of GW & Wade's portfolio in Q4 2023, its #371 holding.
- GW & Wade first reported a position in CME Group in Q1 2015 and has held it in 34 quarters since.
- GW & Wade's CME Group position peaked at $624K in Q4 2016.
- 1,364 funds tracked by Wall St. Rank held CME Group as of Q4 2023.
Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.